MOREADITH RANDALL (Chief Scientific Officer) sold 1.25K shares of SERINA THERAPEUTICS, INC. on the open market
Open‑market sale worth $4.1K. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 12/11/2025ACC: 0001301120-25-000027
Officer· Chief Scientific Officer
Since Feb 2026
-1.25K
Net shares
Net seller
$4.1K
Total sold
2
Open market trades
0B · 2S
6
Total transactions
1.25K acquired · 2.49K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
+600.00
Price / share
$0.06
Trade value
$36.00
% of position
New position
12/9/2025
0.00→600.00
Common Stock
Direct
Shares
−600.00
Price / share
$3.31
Trade value
$1.99K
% of position
New position
12/9/2025
600.00→0.00
Common Stock
Direct
Shares
+645.00
Price / share
$0.06
Trade value
$38.70
% of position
New position
12/10/2025
0.00→645.00
Common Stock
Direct
Shares
−645.00
Price / share
$3.35
Trade value
$2.16K
% of position
New position
12/10/2025
645.00→0.00
Total
Net shares
+0.00
Net value
-$4.07K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/9/2025 | M · Option Exercise | +600.00 | $0.06 | $36.00 | New position | 0.00 | 600.00 |
| Common Stock Direct | 12/9/2025 | S · Sale | −600.00 | $3.31 | $1.99K | New position | 600.00 | 0.00 |
| Common Stock Direct | 12/10/2025 | A · Award | +645.00 | $0.06 | $38.70 | New position | 0.00 | 645.00 |
| Common Stock Direct | 12/10/2025 | S · Sale | −645.00 | $3.35 | $2.16K | New position | 645.00 | 0.00 |
| Total | +0.00 | -$4.07K | ||||||
Derivative Transactions2
Stock Option (right to buy)
Direct
Converts to
Common Stock
600.00 shares
Shares
−600.00
Strike price
0.06
Held after
371.09K
Exercisable
—
12/9/2025
Stock Option (right to buy)
Direct
Converts to
Common Stock
645.00 shares
Shares
−645.00
Strike price
0.06
Held after
370.44K
Exercisable
—
12/10/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock600.00 shares | 12/9/2025 | M · Option Exercise | −600.00 | 0.06 | — | 371.09K |
| Stock Option (right to buy) Direct | Common Stock645.00 shares | 12/10/2025 | M · Option Exercise | −645.00 | 0.06 | — | 370.44K |